Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended December 31, 2025.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Agarwal's Health Care has submitted the quarterly Monitoring Agency Report for Q3 FY26, covering the three months ending December 31, 2025. This is a SEBI-mandated filing that tracks how the company has used the money it raised through its recent IPO (listed in 2024). The monitoring agency, typically a public-sector bank, checks whether the funds are being deployed for the purposes disclosed in the IPO prospectus, such as expansion, equipment, debt repayment, or working capital. The filing itself is a routine regulatory update and does not announce any new business decision. The actual deployment numbers and any observations by the agency would be in the attached report.
This is a routine compliance filing with no direct impact on the stock price. Investors should review the attached report to confirm there are no major deviations from the stated use of IPO proceeds.